IE
THC icon

Israel Englander’s Tenet Healthcare THC Stock Holding History

Israel Englander’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Sell
4,900
-4,600
-48% -$846K ﹤0.01% 4370
2026
Q1 		$1.79M Sell
9,500
-5,900
-38% -$1.24M ﹤0.01% 3979
2025
Q4 		$3.06M Sell
15,400
-26,200
-63% -$5.29M ﹤0.01% 3530
2025
Q3 		$8.45M Buy
41,600
+12,000
+41% +$2.13M ﹤0.01% 2565
2025
Q2 		$5.21M Sell
29,600
-13,700
-32% -$2.06M ﹤0.01% 2946
2025
Q1 		$5.82M Buy
43,300
+31,100
+255% +$4.1M ﹤0.01% 2710
2024
Q4 		$1.54M Sell
12,200
-1,100
-8% -$164K ﹤0.01% 3844
2024
Q3 		$2.21M Sell
13,300
-5,700
-30% -$862K ﹤0.01% 3621
2024
Q2 		$2.53M Buy
19,000
+13,100
+222% +$1.58M ﹤0.01% 3330
2024
Q1 		$620K Sell
5,900
-4,100
-41% -$368K ﹤0.01% 4676
2023
Q4 		$756K Sell
10,000
-20,000
-67% -$1.27M ﹤0.01% 4369
2023
Q3 		$1.98M Buy
30,000
+20,000
+200% +$1.5M ﹤0.01% 3556
2023
Q2 		$814K Sell
10,000
-51,200
-84% -$3.65M ﹤0.01% 4197
2023
Q1 		$3.64M Sell
61,200
-83,400
-58% -$4.64M ﹤0.01% 2897
2022
Q4 		$7.05M Buy
144,600
+1,100
+0.8% +$50.8K ﹤0.01% 2499
2022
Q3 		$7.4M Sell
143,500
-49,000
-25% -$2.91M ﹤0.01% 2506
2022
Q2 		$10.1M Buy
192,500
+92,500
+93% +$6.44M 0.01% 2015
2022
Q1 		$8.6M Buy
100,000
+50,000
+100% +$4.11M ﹤0.01% 2315
2021
Q4 		$4.08M Buy
+50,000
New +$3.65M ﹤0.01% 3112
2020
Q4 		– Sell
-175,000
Closed -$4.29K – 5584
2020
Q3 		$4.29K Buy
+175,000
New +$4.47M 0.01% 1978
2017
Q2 		– Sell
-190,000
Closed -$3.37M – 3865
2017
Q1 		$3.37M Buy
+190,000
New +$3.52M 0.01% 1689
2016
Q4 		– Sell
-20,000
Closed -$453K – 3726
2016
Q3 		$453K Buy
+20,000
New +$521K ﹤0.01% 2645
2015
Q1 		– Sell
-21,200
Closed -$1.07M – 4092
2014
Q4 		$1.07M Buy
+21,200
New +$1.11M ﹤0.01% 2444

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's THC Position: Q2 2026 in Review

Israel Englander increased its Tenet Healthcare (THC) stake by 27% in Q2 2026, buying an estimated $17.8M and bringing the position to 461,487 shares worth $86.3M. The position accounts for 0.03% of the portfolio, ranked #583.

Israel Englander first reported a position in THC in Q2 2013 and has held it in 51 quarters since. The position peaked at $218M in Q2 2023. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Israel Englander held 461,487 shares of Tenet Healthcare worth $86.3M as of Q2 2026.
  • Israel Englander bought 96,768 Tenet Healthcare shares in Q2 2026, an estimated $17.8M.
  • Tenet Healthcare made up 0.03% of Israel Englander's portfolio in Q2 2026, its #583 holding.
  • Israel Englander first reported a position in Tenet Healthcare in Q2 2013 and has held it in 51 quarters since.
  • Israel Englander's Tenet Healthcare position peaked at $218M in Q2 2023.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.